3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Arthritis, Rheumatoid
4
Lymphoma, Non-Hodgkin
3
Lymphoma, B-Cell
3
Hematologic Neoplasms
3
Leukemia
2
Carcinoma, Non-Small-Cell Lung
2
Breast Neoplasms
2
Stomach Neoplasms
1
Spondylitis, Ankylosing
1
Solid Tumors
1
Sarcoma, Kaposi
1
Respiratory Tract Infections
1
Respiratory Distress Syndrome
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Pneumonia
1
Pancreatic Neoplasms
1
Pancreatic Adenocarcinoma
1
Nasopharyngeal Neoplasms
1
Myeloproliferative Disorders
1
Myelodysplastic-Myeloproliferative Diseases
1
Myelodysplastic Syndromes
1
Multi-centric Castleman's Disease
1
Mesothelioma
1
Melanoma
1
Lymphoma, Large B-Cell, Diffuse
1
Lymphoma, Follicular
1
Lymphohistiocytosis, Hemophagocytic
1
Liver Neoplasms
1
Leukemia, Myeloid, Acute
1
Kidney Neoplasms
1
Interventions
Temozolomide
29
Bevacizumab
15
Radiotherapy
13
antineoplaston AS 2-1
8
antineoplaston A10
8
Everolimus
7
Radiation
6
Erlotinib Hydrochloride
6
Radiotherapy, Intensity-Modulated
5
Lomustine
4
veliparib
3
palbociclib
3
Vorinostat
3
Sunitinib
3
Radiotherapy, Conformal
3
Magnetic Resonance Spectroscopy
3
Carmustine
3
Carboplatin
3
temsirolimus
2
selinexor
2
poly ICLC
2
etoposide phosphate
2
cabozantinib
2
Sirolimus
2
Nivolumab
2
Irinotecan
2
Immunoglobulin G
2
Imatinib Mesylate
2
Etoposide
2
Donepezil
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Astrocytoma
×
tocilizumab
×
Clear all
No trials found.